About Esprit Pharma
Esprit Pharma is a company based in East Brunswick (United States) founded in 2005 was acquired by Allergan in September 2007.. Esprit Pharma has raised $219.49 million across 4 funding rounds from investors including Fortress Investment, Apax Partners and Allergan. Esprit Pharma operates in a competitive market with competitors including Lipella, TheraVida, Regenfro Co, Kissei Pharmaceutical and Acerus Pharma, among others.
- Headquarter East Brunswick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Esprit Pharma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$219.49 M (USD)
in 4 rounds
-
Latest Funding Round
$25 M (USD), Series B
Jan 16, 2007
-
Investors
Fortress Investment
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Allergan
(Sep 19, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Esprit Pharma
Esprit Pharma has successfully raised a total of $219.49M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $25.0M
-
First Round
First Round
(07 Sep 2005)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2007 | Amount | Series B - Esprit Pharma | Valuation |
investors |
|
| Aug, 2006 | Amount | Series B - Esprit Pharma | Valuation |
investors |
|
| Mar, 2006 | Amount | Debt – Venture - Esprit Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Esprit Pharma
Esprit Pharma has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Fortress Investment, Apax Partners and Allergan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Equity investments are focused on tech, services, and consumer sectors.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Esprit Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Esprit Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Esprit Pharma Comparisons
Competitors of Esprit Pharma
Esprit Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lipella, TheraVida, Regenfro Co, Kissei Pharmaceutical and Acerus Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat renal diseases
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Esprit Pharma
When was Esprit Pharma founded?
Esprit Pharma was founded in 2005.
Where is Esprit Pharma located?
Esprit Pharma is headquartered in East Brunswick, United States. It is registered at East Brunswick, New Jersey, United States.
Is Esprit Pharma a funded company?
Esprit Pharma is a funded company, having raised a total of $219.49M across 4 funding rounds to date. The company's 1st funding round was a Debt – Venture of $50M, raised on Sep 07, 2005.
What does Esprit Pharma do?
Esprit was focussed on developing drugs for genitourinary and womens health. It had marketed products Sanctura (trospium chloride) for the treatment of overactive bladder (OAB) and Sanctura XR is indicated for the treatment of OAB with symptoms of urge urinary incontinence, urgency and urinary frequency. In September 2007, Allergan acquired Espirit for 370M.
Who are the top competitors of Esprit Pharma?
Esprit Pharma's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
Who are Esprit Pharma's investors?
Esprit Pharma has 7 investors. Key investors include Fortress Investment, Apax Partners, Allergan, Greenspring Associates, and NEA.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.